Granules India Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Granules India Limited Company Profile :

Granules India Limited is an Indian pharmaceutical company engaged in the manufacturing of finished dosages (FDs), pharmaceutical formulation intermediates (PFIs) and active pharmaceutical ingredients (APIs).

The Company’s APIs portfolio includes Paracetamol, Losartan, Ibuprofen, Cetirizine, Metformin HCl, Levocitirizine, Methocarbamol, Rifaximin and Abacavir. Its PFIs comprise single actives, such as Ibuprofen, Guaifenesin, Methocarbamol and Ciprofloxacin, and multiple actives, such as Paracetamol and Caffeine, Paracetamol and Diphenhydramine, Paracetamol and Chlorpheniramine Maleate, and Ibuprofen and Pseudoephedrine HCl. Its FDs include single actives, such as Paracetamol, Guaifenesin, Metformin HCI and Naproxen Sodium, and multiple actives, such as Paracetamol and Guaifenesin; Paracetamol, Codeine Phosphate and Guaifenesin; Ibuprofen and Methocarbamol; Ibuprofen and Pseudoephedrine HCI; Ibuprofen, Pseudoephedrine HCI and Chlorpheniramine Maleate, and Paracetamol and Diphenhydramine HCl.


Granules India ResultsBSE Code : 532482
NSE Symbol : GRANULES
ISIN No. : INE101D01020
Industry : Pharmaceuticals
Face Value : Rs. 1.00


If you are an investor who has shares of Granules India or you are an stock market analyst then i am sure you might for Quarterly Results of Granules India.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Granules India. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Granules India.

Granules India Q1 Results 2016-17 :

Granules India will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Granules India will announce its Q2 FY 2016-17 Results in the month of October 2016.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Granules India will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Granules India will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Granules India will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Granules India Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 1328.49 1431.18
Other Income  6.29  6.02
Total Income  1334.78  1437.2
Expenditure  -1059.06  -1217.14
Interest  -36.66  -39.91
Depreciation  -58.25  -64.33
PBT  180.82  180.14
Tax  -59.85  -61.67
Net Profit  120.96  118.46
Equity  21.67  21.67
EPS  5.85  5.73

Note : If you like this information about Granules India Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.